Comprehensive 2025 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview: Trends, Forecasts, and Growth Drivers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Through 2025?
The market for minimally invasive glaucoma surgery (MIGS) devices has witnessed exponential expansion in previous years. The forecast suggests an escalation from $0.7 billion in 2024 to $0.9 billion in 2025, backed by a compound annual growth rate (CAGR) of 28.3%. This notable development in the historical phase can be linked to the heightened consciousness for blindness prevention, enhanced investments in health infrastructure, increased patient knowledge on progressive vision correction treatments, and augmented government campaigns.

What's the Projected Size of the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by 2029?
The market for Minimally Invasive Glaucoma Surgery (MIGS) devices is predicted to witness substantial expansion in the coming years, reaching a size of $2.42 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 28.1%. Factors attributing to this growth during the forecasted period include a rising incidence of ocular conditions like glaucoma, an increasing elderly population, enhanced healthcare infrastructure, and a developing need for safer and highly effective treatments. The upcoming trends for the given period are projected to revolve around the adoption of MIGS devices, technological improvements, the creation of pioneering MIGS devices, the evolution of advanced implantable devices, and progress in ophthalmic technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Top Growth Drivers in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry: What's Accelerating the Market?
The rising incidence of eye conditions is set to drive growth in the market for minimally invasive glaucoma surgery (MIGS) devices. A gamut of conditions that impact sight and eye health are incorporated in eye disorders. Lifestyle shifts, environmental factors, and ageing demographics contribute to the escalating occurrence of these disorders. Minimally invasive glaucoma surgery (MIGS) devices are ground-breaking instruments applied in dealing with various eye conditions, their primary role being to decrease intraocular pressure (IOP) in a bid to curb or manage glaucoma advancement. For example, predictions from the National Eye Institute, a governmental agency based in the US, state that by 2030, around 2.2 million Americans will be either entirely or partially sightless by the year 2024. As such, the growing incidence of eye conditions acts as a catalyst for growth in the minimally invasive glaucoma surgery (MIGS) devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

What Trends Will Shape the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Through 2029 and Beyond?
Leading corporations in the minimally invasive glaucoma surgery (MIGS) devices field are prioritizing the creation of inventive products like the stent injectable system. Their aim is to fill the gap in glaucoma treatment and enhance patient results. Conveniently, stent injectable systems are MIGS devices that implant a diminutive stent into the body using an injection-like process. This typically involves a specialized delivery method frequently adopted in minimally invasive surgeries to address issues such as blocked or constricted blood vessels. For instance, in August 2022, the US-based Glaukos Corporation, specializing in ophthalmic medical technology, was granted 510(k) clearance for the iStent Infinite Trabecular Micro-Bypass System by the U.S. Food and Drug Administration (FDA). Designed as a groundbreaking three-stent injectable system, the iStent Infinite delivers consistent intraocular pressure (IOP) control for patients suffering from primary open-angle glaucoma (POAG), when their IOP cannot be managed by former medication and surgical treatment.

What Are the Main Segments in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented -

1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users

Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Which Top Companies are Driving Growth in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

Which Regions Will Dominate the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Through 2029?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.